- Home
- KOSS vs RVPH Comparison
KOSS vs RVPH Comparison
Compare KOSS & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOSS
- RVPH
- Stock Information
- Founded
- KOSS 1953
- RVPH 2006
- Country
- KOSS United States
- RVPH United States
- Employees
- KOSS N/A
- RVPH N/A
- Industry
- KOSS Consumer Electronics/Appliances
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- KOSS Consumer Staples
- RVPH Health Care
- Exchange
- KOSS Nasdaq
- RVPH Nasdaq
- Market Cap
- KOSS 63.0M
- RVPH 37.1M
- IPO Year
- KOSS N/A
- RVPH N/A
- Fundamental
- Price
- KOSS $7.60
- RVPH $1.45
- Analyst Decision
- KOSS
- RVPH Strong Buy
- Analyst Count
- KOSS 0
- RVPH 5
- Target Price
- KOSS N/A
- RVPH $14.50
- AVG Volume (30 Days)
- KOSS 234.4K
- RVPH 264.7K
- Earning Date
- KOSS 11-01-2024
- RVPH 11-12-2024
- Dividend Yield
- KOSS N/A
- RVPH N/A
- EPS Growth
- KOSS N/A
- RVPH N/A
- EPS
- KOSS N/A
- RVPH N/A
- Revenue
- KOSS $12,265,069.00
- RVPH N/A
- Revenue This Year
- KOSS N/A
- RVPH N/A
- Revenue Next Year
- KOSS N/A
- RVPH N/A
- P/E Ratio
- KOSS N/A
- RVPH N/A
- Revenue Growth
- KOSS N/A
- RVPH N/A
- 52 Week Low
- KOSS $2.27
- RVPH $0.60
- 52 Week High
- KOSS $18.73
- RVPH $6.80
- Technical
- Relative Strength Index (RSI)
- KOSS 55.73
- RVPH 62.27
- Support Level
- KOSS $6.88
- RVPH $1.15
- Resistance Level
- KOSS $8.50
- RVPH $1.54
- Average True Range (ATR)
- KOSS 0.38
- RVPH 0.11
- MACD
- KOSS 0.11
- RVPH 0.02
- Stochastic Oscillator
- KOSS 57.65
- RVPH 82.00
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-cancelling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.